Adaptive Uterine Fibroid Treatment Systems for Specialized Environments
Legal Citation
Summary of the Inventive Concept
The present inventive concept relates to specialized uterine fibroid treatment systems designed for high-altitude, emergency response, remote, high-security, and extreme weather environments, leveraging the original collagenase-based method for targeted niche applications.
Background and Problem Solved
The original patent disclosed a method and product for treating uterine fibroids using purified collagenase. However, this invention has limitations in addressing the unique challenges of treating uterine fibroids in specialized environments, such as high-altitude regions, emergency response situations, remote or underserved areas, high-security facilities, and extreme weather conditions. The present inventive concept addresses these limitations by adapting the collagenase-based method for these specific contexts.
Detailed Description of the Inventive Concept
The present inventive concept encompasses a range of specialized systems and methods for treating uterine fibroids in niche environments. For high-altitude environments, a portable collagenase composition delivery device is adapted for use in low-oxygen conditions. In emergency response situations, a rapid-action collagenase composition is administered through a handheld injector device. For remote or underserved areas, a pre-packaged collagenase composition kit is provided with a portable delivery device and instructions for use in resource-constrained environments. In high-security facilities, a secure collagenase composition storage unit, a restricted-access delivery device, and a monitoring system for tracking treatment progress are employed. Finally, for extreme weather conditions, a weather-resistant collagenase composition is administered through a weather-sealed delivery device. Each of these specialized systems is designed to overcome the unique challenges of treating uterine fibroids in these environments.
Novelty and Inventive Step
The present inventive concept introduces novel adaptations of the original collagenase-based method, including portable delivery devices, rapid-action compositions, pre-packaged kits, secure storage units, and weather-resistant compositions. These adaptations represent a non-obvious extension of the original patent, providing a new and innovative approach to treating uterine fibroids in specialized environments.
Alternative Embodiments and Variations
Alternative embodiments of the present inventive concept could include variations in the composition and delivery device design, such as using different collagenase concentrations, incorporating additional therapeutic agents, or integrating with existing medical devices. Furthermore, the inventive concept could be adapted for use in other specialized environments, such as space exploration or disaster relief scenarios.
Potential Commercial Applications and Market
The present inventive concept has significant commercial potential in the medical device and pharmaceutical industries, particularly in niche markets serving high-altitude regions, emergency response situations, remote or underserved areas, high-security facilities, and extreme weather conditions. The targeted applications could include military, humanitarian, and commercial healthcare providers operating in these specialized environments.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/48 |
| A | A61 | A61K9/0019 |
| A | A61 | A61K9/0034 |
| A | A61 | A61K9/1075 |
| A | A61 | A61K38/43 |
| A | A61 | A61K38/4886 |
| A | A61 | A61K45/06 |
| C | C12 | C12Y304/24003 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technologies for targeted therapeutic interventions, specifically minimally invasive treatment of uterine fibroids using enzymatic compositions, requiring advanced knowledge in medical biotechnology, interventional medical devices, and pharmaceutical formulation
Person of Ordinary Skill (PHOSITA) Profile
A medical professional with expertise in interventional gynecology, biotechnology, and medical device engineering, possessing advanced degrees, familiarity with enzymatic treatments, and understanding of adaptive medical technologies for specialized clinical environments
Obviousness Rationale
A person having ordinary skill would recognize that the specialized uterine fibroid treatment systems represent predictable variations of the source patent's core collagenase treatment method. The PTD's environmental adaptations leverage known medical device design principles and standard engineering approaches for modifying therapeutic delivery systems. These variations demonstrate standard problem-solving techniques within medical technology by addressing specific contextual challenges using fundamentally similar therapeutic mechanisms.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,685 |
|---|---|
| Title | Treatment method and product for uterine fibroids using purified collagenase |
| Assignee(s) | Duke University, BioSpecifics Technologies LLC |